 In a statement, Purdue Pharma tells News 8 today's ruling is heart-crushing because it invalidates a settlement supported by nearly all of our creditors that would have delivered billions of dollars for victim compensation, opioid crisis abatement, and overdose rescue and addiction treatment medicines. The U.S. trustee estimates the now-defunct deal would have provided opioid victims like Doug Schuman between $3,500 and $48,000. He says he could have used that money. Dismayed.